This brand name is authorized in United States. It is also authorized in Austria, Estonia, France, Poland, Spain, Tunisia.
The drug PYLERA contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
R3O80H60KX - BISMUTH SUBCITRATE POTASSIUM
|
|
Under the effect of gastric acid, a precipitate is formed from bismuth subcitrate, which adheres primarily to the ulcerated area and inhibits the activity of pepsin. Bismuth subcitrate contributes to the healing of a high percentage of gastric and duodenal ulcers. |
|
2
|
UNII
140QMO216E - METRONIDAZOLE
|
|
Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites. |
|
3
|
UNII
P6R62377KV - TETRACYCLINE HYDROCHLORIDE
|
|
Tetracyclines are taken up into sensitive bacterial cells by an active transport process. Once within the cell they bind reversibly to the 30S subunit of the ribosome, preventing the binding of aminoacyl transfer RNA and inhibiting protein synthesis and hence cell growth. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| PYLERA Capsule | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A02BD08 | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BD Combinations for eradication of Helicobacter pylori | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1688698, 1764457, 1775347 |
| ES | Centro de información online de medicamentos de la AEMPS | 75095 |
| FR | Base de données publique des médicaments | 63941426 |
| PL | Rejestru Produktów Leczniczych | 100265853, 100456052, 100462170 |
| TN | Direction de la Pharmacie et du Médicament | 15233011 |
| US | FDA, National Drug Code | 58914-601 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.